Register for the World CNS Summit South Korea
참가 등록
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in USD.
Register by Friday, 28 August & Save up to $1,100
Drug Developer Pricing*
Conference + 2 Workshops
(Save $600)
$1,599
On the Door: $2,199
Conference Only
(Save $600)
$1,199
On the Door: $1,799
Academic Pricing**
Conference + 2 Workshops
(Save $600)
$1,299
On the Door: $1,899
Conference Only
(Save $600)
$999
On the Door: $1,599
Service Provider Pricing***
Conference + 2 Workshops
(Save $1,100)
$4,049
On the Door: $5,149
Conference Only
(Save $600)
$3,249
On the Door: $3,849
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when three or more delegates from one company book and pay at the same time.
10% Off
When registering 2 attendees from one company
15% Off
When registering 3 attendees from one company
20% Off
When registering 4+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help in the booking process, contact us and one of the team will get back to you.
Explore the Full Event Guide
공식 아젠다를 다운로드하여 다음 내용을 확인하세요
- Cutting-edge insights from pioneering Korean innovators, alongside voices from Japan, China, US, India and Europe
- Presentations containing new data from AriBio, Mthera Pharma, ADEL, JCR Pharmaceuticals, Genuv and more
- Dedicated networking opportunities with global experts working on neurodegenerative, rare neurodevelopmental, and neuropsychiatric disorders
- Strategic investment insights from global representatives at Novartis, Takeda, Eli Lilly, Johnson & Johnson and more
